Is Brookdale Senior Living, Inc. overvalued or undervalued?
As of May 6, 2021, Brookdale Senior Living, Inc. is considered overvalued and risky due to its negative financial metrics, including a Price to Book Value of 11.15, an EV to EBITDA ratio of 3.13, and a Return on Equity of -111.50%, despite a strong year-to-date stock performance of 59.24%.
As of 6 May 2021, the valuation grade for Brookdale Senior Living, Inc. changed from attractive to risky, indicating a shift in perception regarding its financial health and market position. The company appears to be overvalued given its significant negative metrics, including a Price to Book Value of 11.15 and an EV to EBITDA ratio of 3.13, which suggests that the market may be pricing in more value than the company can deliver. Additionally, the Return on Equity (ROE) stands at a staggering -111.50%, further highlighting the challenges the company faces.In comparison to its peers, Brookdale's P/E ratio is not applicable due to its loss-making status, while Universal Health Services, Inc. has a P/E of 9.2050, indicating a more favorable valuation. Surgery Partners, Inc., also classified as risky, has a higher EV to EBITDA ratio of 8.4432, suggesting that Brookdale may be less attractive relative to its competitors. Despite recent stock performance showing a 59.24% year-to-date return compared to the S&P 500's 12.22%, the overall valuation metrics indicate that Brookdale Senior Living, Inc. is overvalued in the current market context.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
